Chapter One — 1.1 Background to the Study

Over the past decade, the relationship between tobacco control policies and prevalence of non-communicable diseases has become a subject of considerable debate among scholars and industry practitioners alike, particularly within the context of Selected States in Northern Nigeria where operating conditions differ markedly from more developed markets.

Selected States in Northern Nigeria presents a useful setting for examining this relationship precisely because the conditions there — structural, regulatory, and behavioural — differ from those typically assumed in the broader literature, most of which draws on evidence from more developed economies.

1.2 Statement of the Problem

Despite a growing body of literature on tobacco control policies, there remains limited consensus on the precise nature of its relationship with prevalence of non-communicable diseases, particularly within Selected States in Northern Nigeria. Many organizations continue to make decisions about tobacco control policies without a clear, evidence-based understanding of how those decisions ultimately affect prevalence of non-communicable diseases. This gap between practice and empirical understanding is the central problem this study seeks to address.

1.3 Objectives of the Study

1. To examine the effect of Tobacco Control Policies on prevalence of non-communicable diseases in Selected States in Northern Nigeria.
2. To assess the extent to which tobacco control policies influences prevalence of non-communicable diseases within the study area.
3. To identify the challenges associated with tobacco control policies in relation to prevalence of non-communicable diseases.
4. To recommend strategies for optimizing tobacco control policies in order to improve prevalence of non-communicable diseases.

1.4 Research Questions

1. What is the effect of tobacco control policies on prevalence of non-communicable diseases in Selected States in Northern Nigeria?
2. To what extent does tobacco control policies influence prevalence of non-communicable diseases within the study area?
3. What challenges are associated with tobacco control policies in relation to prevalence of non-communicable diseases?
4. What strategies can be adopted to optimize tobacco control policies in order to improve prevalence of non-communicable diseases?

1.5 Significance of the Study

Beyond its academic contribution to the field of public health, this study has practical value for management teams within Selected States in Northern Nigeria seeking to understand how tobacco control policies translates into measurable outcomes around prevalence of non-communicable diseases. It is equally useful to students and future researchers looking for a localized empirical reference on this relationship.

1.6 Scope of the Study

In terms of scope, this study confines itself to Selected States in Northern Nigeria, focusing specifically on how tobacco control policies relates to prevalence of non-communicable diseases within that setting. Findings are interpreted within these boundaries rather than as universal claims applicable to every organization or market.